Theraject Asia applies for microneedle patent in US

The S.Korean company’s static pressure syringe technology utilizes its expertise in drug-injecting microneedles

Theraject Asia applies for microneedle patent in US
Ji-Hyun Lee 1
2023-10-27 11:33:14 bluesky@hankyung.com
Bio & Pharma

South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a constant pressure model that controls active drug penetration and resolves effect reproducibility.

As a system for delivering transdermal drugs using a microneedle hundreds of micrometers long, a microneedle can administer a variety of medicines depending on its size, strength and material. Though microneedles are growing in prominence as a cutting-edge technology, know-how in standardized transdermal injection is needed for drug reproducibility when applied to the skin.

Theraject Asia has secured technology for static pressure syringes that combines know-how in drug-injecting microneedles, enabling easy application to the skin under standardized physical conditions.

The company on Wednesday signed a joint research agreement with JW Pharmaceutical to use this technology for development of a hair loss treatment using microneedles.

“In 2019, we received from Theraject in the US an exclusive license for the original patent for a dissolvable pharmaceutical microneedle,” Theraject Asia CEO Kim Kyeong-dong said. “Since 2020, our focus has been finding methods to overcome obstacles to commercial application of a medical microneedle patch.”

Write to Ji-Hyun Lee at bluesky@hankyung.com
#Theraject Asia #microneedle #US patent #apply #drug-injecting microneedles

Raphas microneedle passes US FDA's cGMP inspection

Raphas microneedle passes US FDA's cGMP inspection

Raphas' acne treatment microneedle patch product  South Korea's microneedle maker Raphas Co. announced on Wednesday that it has passed the Current Good Manufacturing Practice (cGMP) inspection by the US Food and Drug Administration (FDA) for its microneedle patch used in acne treatment m

GeneOne Life Science gets patent for coated microneedle tech in China

GeneOne Life Science gets patent for coated microneedle tech in China

South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Property Office for its self-limiting electrospray deposition technology (SLED), the core know-how for the transdermal drug delivery system coated m

S.Korea's microneedle maker Raphas to enter US market

S.Korea's microneedle maker Raphas to enter US market

South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics sector, with its US-based sales company to start activity in June to expand the company's acne patch business. Raphas will also build as early

(* comment hide *}